In a study that compared changes in body composition and insulin resistance (as assessed by homeostasis model assessment of insulin resistance [HOMA-IR]) in people with or without COVID-19, the former showed an increase in percentage fat mass despite a reduction in BMI, and significant increases in fasting plasma glucose, insulin, and HOMA-IR compared to pre-COVID-19 (204). This evidence concerns the gene INS and COVID-19.